Page last updated: 2024-11-07

tei 5103

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

TEI 5103: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133826
SCHEMBL ID1133035
SCHEMBL ID1133033
MeSH IDM0131828

Synonyms (22)

Synonym
2ox5ez739o ,
unii-2ox5ez739o
rotraxate hcl
82085-94-7
cumelon
tei-5103
rotraxate hydrochloride
ccris 1133
trans-4-((4-(aminomethyl)cyclohexyl)carbonyl)benzenepropanoic acid hydrochloride
benzenepropanoic acid, 4-((4-(aminomethyl)cyclohexyl)carbonyl)-, hydrochloride, trans-
tg-51
tei 5103
3-(p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl) propionic acid hydrochloride
SCHEMBL1133035
SCHEMBL1133033
rotraxate hydrochloride [jan]
rotraxate hydrochloride [mi]
trans-4-[[4-(aminomethyl)cyclohexyl]carbonyl]benzenepropanoic acid hydrochloride
Q27255271
3-{4-[4-(aminomethyl)cyclohexane-1-carbonyl]phenyl}propanoic acid--hydrogen chloride (1/1)
DTXSID101002470
3-[4-[4-(aminomethyl)cyclohexanecarbonyl]phenyl]propanoic acid;hydrochloride

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
") given 30 min prior to TEI-5103 dosing slightly attenuated this protective effect."( Effect of 3-[p-(trans-4-aminomethylcyclohexylcarbonyl)phenyl]propionic acid hydrochloride on gastric mucosal barrier.
Hoshina, K; Naruchi, T; Takeshita, T; Yamazaki, N, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (54.55)18.7374
1990's1 (9.09)18.2507
2000's0 (0.00)29.6817
2010's1 (9.09)24.3611
2020's3 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.40 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.04 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]